Antibiotic Resistance Lab Network

The Antibiotic Resistance Lab Network (ARLN) is a national network of public health and clinical laboratories coordinated by the Centers for Disease Control and Prevention (CDC). The network was established to enhance the nation's capacity to identify, respond to, and combat antibiotic resistance.

Pronunciation

An-ti-bi-ot-ic Re-sis-tance Lab Net-work

Etymology

The term "Antibiotic Resistance Lab Network" is derived from the English language. "Antibiotic" is a compound word from the Greek anti (against) and bios (life), "Resistance" comes from the Latin resistere (to withstand), "Lab" is an abbreviation of "laboratory", and "Network" comes from the Old English netweorc (net work).

Related Terms

Overview

The Antibiotic Resistance Lab Network was established by the CDC in 2016 as part of the National Action Plan for Combating Antibiotic-Resistant Bacteria. The network consists of seven regional labs, the National Tuberculosis Molecular Surveillance Center, and the Antibiotic Resistance Isolate Bank. The ARLN provides advanced testing capabilities to detect and respond to multidrug-resistant organisms and carbapenem-resistant Enterobacteriaceae.

Function

The ARLN supports nationwide efforts to identify outbreaks of antibiotic resistance and provides data to inform policy and intervention strategies. It also provides resources and training to state and local public health labs to enhance their capacity to detect and respond to antibiotic resistance threats.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Antibiotic Resistance Lab Network